Objectives

SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of infectious and inflammatory skin diseases.

SkinDermic® wants to complete multiple Phase-1 (proof of concept) and Phase-2 clinical trials of its First-in-Class Topical treatments for acne and Kaposi’s sarcoma.